Dig Your Heels In: A Working Woman’s Series with Jackie Pasierbowicz

“Female” and “construction” are two words that are not typically paired. But Jackie Pasierbowicz, VP of Global Sales and Marketing at TAS Energy, is helping change this. Pasierbowicz discussed the current gender dynamic in the industry and how to promote female involvement with Host Gabrielle Bejarano.

Pasierbowicz started in the software industry and moved to TAS for a better work-life balance, where she began in marketing and shifted to sales. TAS reduces onsite construction risk by constructing offsite and shipping to the main site. Pasierbowicz said, “I’ve really learned and been able to adopt some of the day-to-day engagements to learn more about the engineering aspect of things while I don’t necessarily need to be an expert to do what I do on a day-to-day basis.”

The Bureau of Labor Statistics cites that just under 89 percent of workers in the construction industry are male. Of the ten percent of females in the industry, only 14 percent attain a VP or “C” level position. Pasierbowicz explained this is partly because females are uneducated on roles they can play in this industry. Those who enter it often do because of family members who transfer their interest. However, there is ample opportunity for women to enter and grow in the industry. “There’s a vast amount of opportunities out there for women in the industry and more often than not, I find that most men want to cultivate those women and really help them grow within their role,” Pasierbowicz stated.

Pasierbowicz suggested female VPs and CEOs should mentor and nurture new women in the industry and cross-train them in other aspects of the business, so their growth potential is greater. This can also assist in forming a more cohesive team. Pasierbowicz explained, “Sometimes, you have to walk a fine line to make people feel valued and that they trust you. If you have a team that trusts you, that knows that you value them, then as a leader, they will always not only do what’s right for the company but what’s right for the team and what’s right for themselves.”

As for advice Pasierbowicz has for females who are new to the industry, she said, “No matter where you come into the industry, what knowledge base you have, there’s always room for growth and it’s okay for us to challenge ourselves to learn more.”

To hear more from Dig Your Heels In, visit Marketscale’s show page.

Follow us on social media for the latest updates in B2B!

Image

Latest

AMAG Technology
AMAG Technology: Control, Reliability, and Customer-First Supply Chain Excellence
April 2, 2025

At AMAG Technology, being customer-obsessed goes beyond a mindset—it’s built into every part of the operation. One of the company’s greatest strengths lies in its ability to manufacture its own products, offering a level of supply chain control that few competitors can match. Allan Price, Head of Global Supply Chain at AMAG, emphasizes how this…

Read More
visitor management solution
Reinventing Visitor Management Solution with Symmetry GUEST
April 2, 2025

In an age where speed and security are paramount, the traditional paper logbook is becoming a relic of the past. AMAG Technology’s Symmetry Guest system offers a modern, digital solution that redefines the way organizations welcome and manage visitors. Gone are the days of long lines and confusion at the front desk—Symmetry Guest empowers hosts…

Read More
AMAG
Driven by Customers, Defined by Innovation: Inside AMAG’s Customer-Obsessed Approach
April 2, 2025

AMAG Technology continues to strengthen its customer-obsessed culture by actively listening to both internal and external voices. As shared by Kyle Gordon, Executive Vice President of Global Sales, Marketing, & Commercial Excellence, the company is focused on improving processes, responding with speed, and driving innovation—while honoring its legacy and delivering unique value within the industry.

Read More
biotech
Biotech Moves Smarter: IDDI Powers Data-Driven Drug Innovation
April 2, 2025

As biotech innovation accelerates, small and mid-size pharmaceutical companies are becoming key players in bringing new treatments to market. Yet many of these organizations face steep challenges when navigating clinical trial design, regulatory approval, and data integrity. According to a McKinsey Global Institute report, industries like biotech could help generate up to $50 trillion…

Read More